Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
151 studies found for:    Neurofibromatosis
Show Display Options
Rank Status Study
21 Enrolling by invitation Analysis of Plasma for Diagnosis and Follow-up of Neurofibromatosis Type 1
Condition: Neurofibromatosis 1
Intervention: Other: Blood sample
22 Completed Neuropsychological Impairment and Quality of Life in Neurofibromatosis Type 1
Condition: Neurofibromatosis Type 1
Intervention: Other: Neuropsychological examination and quality of life measures
23 Completed Adaptation and Quality of Life Among Adults With Neurofibromatosis Type I
Conditions: Neurofibromatosis Type 1;   Von Recklinghausen Disease;   NF1
Intervention:
24 Completed Pirfenidone in Treating Young Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas
Conditions: Neurofibromatosis Type 1;   Precancerous Condition
Intervention: Drug: pirfenidone
25 Terminated
Has Results
Fludeoxyglucose F 18 Positron Emission Tomography and Magnetic Resonance Perfusion Imaging in Patients With Neurofibromatosis 1 and Plexiform Neurofibroma
Conditions: Neurofibromatosis Type 1;   Precancerous Condition
Interventions: Radiation: fludeoxyglucose F 18;   Radiation: gadopentetate dimeglumine
26 Active, not recruiting Cabozantinib for Plexiform Neurofibromas (PN) in Subjects With NF1 (16 Years +)
Conditions: NF1;   Neurofibromatosis;   Plexiform Neurofibromas
Intervention: Drug: Cabozantinib
27 Completed Trial to Evaluate the Safety of Lovastatin in Individuals With Neurofibromatosis Type I (NF1)
Condition: Neurofibromatosis 1
Interventions: Drug: Lovastatin;   Drug: placebo pill
28 Completed Reliability of Functional Outcome Measures in Neurofibromatosis 1
Condition: Neurofibromatosis 1, NF1
Intervention:
29 Completed Topical Imiquimod 5% Cream for Treatment of Cutaneous Neurofibromas in Adults With Neurofibromatosis 1
Conditions: Neurofibromatosis Type 1;   Cutaneous Neurofibromas
Intervention: Drug: Imiquimod 5% Cream
30 Completed Everolimus for Treatment of Disfiguring Cutaneous Lesions in Neurofibromatosis1 CRAD001CUS232T
Condition: Neurofibromatosis 1
Intervention: Drug: Everolimus
31 Unknown  First Clinical Study of Erbium - Yttrium Aluminium Garnet (YAG) Laser Vaporization of Cutaneous Neurofibromas
Condition: Cutaneous Neurofibromas
Intervention: Procedure: Erbium-YAG laser vaporization
32 Completed
Has Results
Phase II Study of Everolimus (RAD001) in Children and Adults With Neurofibromatosis Type 2
Condition: Neurofibromatosis Type II
Intervention: Drug: Everolimus (RAD001) , Afinitor®
33 Recruiting Study of Axitinib in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas
Conditions: Neurofibromatosis Type 2;   Vestibular Schwannomas
Intervention: Drug: Axitinib
34 Suspended PTC299 for Treatment of Neurofibromatosis Type 2
Condition: Neurofibromatosis 2
Intervention: Drug: PTC299
35 Terminated
Has Results
Efficacy and Safety of RAD001 in Treating Plexiform Neurofibromas (PN) Associated With Neurofibromatosis (NF1)
Condition: Plexiform Neurofibroma Associated With Neurofibromatosis Type 1
Intervention: Drug: Everolimus (RAD001)
36 Completed NF1-Attention: Study of Children With Neurofibromatosis Type 1 Treated by Methylphenidate
Condition: Neurofibromatosis Type 1
Intervention: Drug: methylphenidate
37 Active, not recruiting Medical Treatment of "High-Risk" Neurofibromas
Condition: Neurofibromatosis 1
Interventions: Drug: Peg-Interferon alpha-2b;   Drug: Celecoxib (Celebrex);   Drug: Temozolomide (temodar);   Drug: Vincristine Sulfate (Oncovin)
38 Completed Combination Chemotherapy in Treating Patients With Neurofibromatosis and Progressive Plexiform Neurofibromas
Conditions: Neurofibromatosis Type 1;   Precancerous Condition
Interventions: Drug: Methotrexate;   Drug: Vinblastine
39 Recruiting Photodynamic Therapy for Benign Dermal Neurofibromas
Condition: NEUROFIBROMATOSIS 1
Intervention: Procedure: PDT Treatment
40 Unknown  Analysis of Peripheral Nerve Sheath Tumors (PNSTs) in Neurofibromatosis Type 1 (NF1) Patients
Condition: Neurofibromatosis Type 1
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years